Filing Details

Accession Number:
0000899243-16-029739
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-22 16:07:21
Reporting Period:
2016-09-20
Filing Date:
2016-09-22
Accepted Time:
2016-09-22 16:07:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1512762 Coherus Biosciences Inc. CHRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420822 M Dennis Lanfear Coherus Biosciences, Inc.
333 Twin Dolphin Drive, Suite 600
Redwood City CA 94065
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Disposition 2016-09-20 4,010 $31.75 1,337,616 No 4 S Indirect By Trust
Common Stock, $0.0001 Par Value Disposition 2016-09-21 50 $31.75 1,337,566 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.0001 Par Value 71,635 Direct
Common Stock, $0.0001 Par Value 86,965 Indirect By LLC
Footnotes
  1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
  2. The transaction was executed in multiple trades in prices ranging from $31.75 to $31.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
  3. These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
  4. These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.